AEON Biopharma, Inc. Annual Operating Income (Loss) in USD from 2021 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
AEON Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2022.
  • AEON Biopharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.02M, a 98.6% increase year-over-year.
  • AEON Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$48.4M, a 2402% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$48.4M -$46.5M -2402% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2021 -$1.94M Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.